Abstract P4-11-08: A Pilot Safety and Feasibility Study of Concurrent Capecitabine and External Beam Irradiation in the Adjuvant Treatment of High Risk Early Stage Breast Cancer

Mapping Intimacies ◽

10.1158/0008-5472.sabcs10-p4-11-08 ◽

2010 ◽

Author(s):

DP Garwood ◽

A Spangler ◽

PM DeRose ◽

HC Li ◽

C Osborne ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Feasibility Study ◽

Adjuvant Treatment ◽

Early Stage ◽

Early Stage Breast Cancer ◽

External Beam ◽

Beam Irradiation ◽

External Beam Irradiation

Download Full-text

Toxicity of Concurrent Capecitabine and External Beam Irradiation in the Adjuvant Treatment of High Risk Breast Cancer: A Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.435 ◽

2009 ◽

Vol 75 (3) ◽

pp. S187-S188

Author(s):

P.M. DeRose ◽

T. Boike ◽

J.H. Heinzerling ◽

R. Abdulrahman ◽

A. Spangler ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Adjuvant Treatment ◽

Phase Ii Trial ◽

External Beam ◽

Beam Irradiation ◽

External Beam Irradiation ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Risk Breast Cancer

Download Full-text

Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer

Medical Physics ◽

10.1118/1.2799579 ◽

2007 ◽

Vol 34 (12) ◽

pp. 4640-4648 ◽

Cited By ~ 11

Author(s):

Yongbok Kim ◽

David S. Parda ◽

Mark G. Trombetta ◽

Athanasios Colonias ◽

E. Day Werts ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Early Stage Breast Cancer ◽

External Beam ◽

Beam Irradiation ◽

External Beam Irradiation ◽

Dosimetric Comparison

Download Full-text

Abstract P1-13-11: Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: preliminary results from a phase 2, single-arm feasibility study

10.1158/0008-5472.sabcs12-p1-13-11 ◽

2012 ◽

Author(s):

TA Traina ◽

C Hudis ◽

M Fornier ◽

D Lake ◽

R Lehman ◽

...

Keyword(s):

Breast Cancer ◽

Feasibility Study ◽

Adjuvant Treatment ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Phase 2 ◽

Eribulin Mesylate ◽

Preliminary Results ◽

Dose Dense

Download Full-text

Phase 2 feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate with or without prophylactic growth factor (GF) for adjuvant treatment of early-stage breast cancer (EBC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps670 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS670-TPS670

Author(s):

Tiffany A. Traina ◽

Peter Andrew Kaufman ◽

Karen Anne Cadoo ◽

Clifford A. Hudis ◽

Cassandra Chang ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Feasibility Study ◽

Adjuvant Treatment ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Phase 2 ◽

Eribulin Mesylate ◽

Dose Dense

Download Full-text

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2015.07.007 ◽

2016 ◽

Vol 16 (1) ◽

pp. 31-37 ◽

Cited By ~ 9

Author(s):

John W. Smith ◽

Svetislava Vukelja ◽

Anthony D. Hoffman ◽

Vicky E. Jones ◽

Kristi McIntyre ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Feasibility Study ◽

Phase Ii ◽

Adjuvant Treatment ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Estrogen Receptor Positive

Download Full-text

Denosumab Versus Placebo as Adjuvant Treatment for Women With Early-Stage Breast Cancer at High Risk of Disease Recurrence (D-CARE): An in Progress, Phase 3 Clinical Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)32883-0 ◽

2012 ◽

Vol 23 ◽

pp. ix115

Author(s):

R.E. Coleman ◽

C. Barrios ◽

R. Bell ◽

D.M. Finkelstein ◽

H. Iwata ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

High Risk ◽

Adjuvant Treatment ◽

Early Stage ◽

Disease Recurrence ◽

Early Stage Breast Cancer ◽

Phase 3 ◽

Risk Of Disease

Download Full-text

Abstract OT2-6-02: Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): A global, placebo-controlled, randomized, double-blind, phase 3 clinical trial

10.1158/0008-5472.sabcs13-ot2-6-02 ◽

2013 ◽

Cited By ~ 1

Author(s):

PE Goss ◽

CH Barrios ◽

A Chan ◽

DM Finkelstein ◽

H Iwata ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

High Risk ◽

Adjuvant Treatment ◽

Early Stage ◽

Disease Recurrence ◽

Early Stage Breast Cancer ◽

Phase 3 ◽

Double Blind ◽

Risk Of Disease

Download Full-text

Long-Term Results of a Prospective Pilot Safety and Feasibility Study of Adjuvant Concurrent Capecitabine and External Beam Irradiation Demonstrates Tolerability and Efficacy in High-Risk Locally Advanced Breast Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.531 ◽

2017 ◽

Vol 99 (2) ◽

pp. S215 ◽

Cited By ~ 1

Author(s):

D.T. Vo ◽

A.S. Rahimi ◽

J. O'shaughnessy ◽

A.E. Spangler ◽

J. Li ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Advanced Breast Cancer ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Long Term Results ◽

External Beam ◽

Beam Irradiation ◽

External Beam Irradiation

Download Full-text

Corrigendum to ‘VP1-2021: Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer’

Annals of Oncology ◽

10.1016/j.annonc.2021.04.004 ◽

2021 ◽

Author(s):

T. Bachelot ◽

F. Dalenc ◽

S. Chabaud ◽

P. Cottu ◽

D. Allouache ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Early Stage ◽

Early Stage Breast Cancer

Download Full-text

Comparison of the morbidity in men with intermediate and high-risk prostate cancer treated with either I-125 or Pd-103 brachytherapy combined with external beam irradiation

European Urology Supplements ◽

10.1016/s1569-9056(19)30706-7 ◽

2019 ◽

Vol 18 (1) ◽

pp. e973

Author(s):

N. Stone ◽

V. Skouteris ◽

A. Dounis ◽

E. Koutsouveli ◽

D. Katsochi ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

External Beam ◽

Beam Irradiation ◽

External Beam Irradiation ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text